|
1
|
- Christy Hanson, PhD, MPH
- PATH
- May 30, 2005
- CCIH Annual Conference
|
|
2
|
- TB is infectious, curable disease
- 8.8 million new cases of TB in 2003
- TB is the primary cause of death for PLWHA in Africa
- Highly cost-effective treatment strategy
- Only half of new cases were detected in 2003
|
|
3
|
|
|
4
|
|
|
5
|
|
|
6
|
|
|
7
|
|
|
8
|
- 70% case detection
- 85% treatment success
|
|
9
|
- Political commitment
- Standardized treatment regimen
- Available free of charge to patients in public sector
- Diagnosis by smear microscopy
- Directly-observed treatment (DOT)
- Standardized recording and reporting
|
|
10
|
- China
- DOTS areas: 44% decrease in TB prevalence (1990-2000)
- Non-DOTS areas: 12% decrease in TB prevalence
- Global level
- DOTS areas: treatment success rates average 80%
- Non-DOTS areas: around 50%
|
|
11
|
|
|
12
|
|
|
13
|
- Dual epidemic of TB/HIV
- Low case detection rates
|
|
14
|
|
|
15
|
|
|
16
|
|
|
17
|
|
|
18
|
- None are high-income countries
- 78% have GNP per capita of less than $760 (low income)
- Estimate: over 50% new TB patients without access to DOTS are living on
less than $2 per day
|
|
19
|
|
|
20
|
|
|
21
|
|
|
22
|
|
|
23
|
|
|
24
|
|
|
25
|
|
|
26
|
|
|
27
|
- Overcrowding
- Malnutrition
- TB anemia, low retinol & zinc, wasting
- Vit D deficiency 10x risk of TB disease
- Gender differentials
- Higher prevalence among men
- Women:faster breakdown to TB disease (2x)
- Marginalized populations
|
|
28
|
|
|
29
|
- Impoverishing effects of TB
- Economic: 20-30% of household wages
- Social: stigma
- Women fear social impoverishment, men fear economic
- Delayed treatment seeking
- Worse outcomes?
- Barriers to access
- Inhibited continuity
- In absence of treatment, 50% will die
|
|
30
|
|
|
31
|
- Millennium Development Goals
- Halve the prevalence of TB disease and deaths between 1990 and 2015
- Poverty-Reduction Strategy Papers
- Re-orienting development agenda toward pro-poor approaches
- Debt-relief, increased funds for social sectors
- Global Fund for AIDS, TB and malaria
- 4 rounds of applications funded
- $1 billion for TB (13%)
|
|
32
|
|
|
33
|
|
|
34
|
|
|
35
|
|
|
36
|
|
|
37
|
- DOTS expansion and adaptation
- Global TB Drug Facility
- Stop TB Partnership
- Collaboration with NGOs, partners
- Social and resource mobilization
- 2002 Theme: TB and poverty
- Research
- Benefit - incidence
- Evaluating what works
- Understanding what matters to the poor (demand)
|
|
38
|
- Cambodia: food incentives for all TB patients
- Uganda: community-based care
- China: increased financing for TB control in poorest areas
- Kenya: mobile treatment facilities for migrant populations
- Mauritania: salary supplements for health workers in poor, rural areas
|
|
39
|
- Is the health system responding to poverty dimension of TB?
|
|
40
|
|
|
41
|
|
|
42
|
|
|
43
|
|
|
44
|
|
|
45
|
|
|
46
|
|
|
47
|
|
|
48
|
|
|
49
|
|
|
50
|
- TB patients actively seeking care
- Poor disproportionately represented at all stages
- Research: prevalence distribution by wealth
- Social science research: why?
- Private sector: competitive, well used
- Cost & geographic access similar
- District variance: lessons to be learned from successful districts
- Modeling of system and district-level determinants impacting case
detection
- New initiatives: test strategies to reach the poor
|
|
51
|
- TB disproportionately affects the poorest countries & poorest
populations
- TB has impoverishing effects on individuals and households
- TB can be cured
- DOTS is cost-effective and adaptable to become pro-poor
- Equity approach to the expansion of DOTS needed
- Attain global targets
- Serve local populations
|
|
52
|
- “The authorities don’t seem to see poor people. Everything about the
poor is despised, and above all, poverty is despised.”
- - Brazil, 1995
|